Posted by Jedi on April 21, 2007, at 13:28:56
In reply to NARDIL QUESTIONS, posted by natedog539 on April 20, 2007, at 18:09:59
Hi natedog539,
I was on Nardil for most of the past ten years. I'm currently doing a trial of Parnate becase of the weight gain side effect that affects many (not all) Nardil users. I was taking 90mg per day of Nardil. The standard dosage is 1mg/kg of body weight. Of course more or less works for some people. IMHO Nardil + clonazepam is the GOLD standard for treatment resistant Atypical Depression and Social Anxiety Disorder. Again, in my opinion, these meds should be the 2nd tier when the first SSRI does not work. Most PDOCS, because of unfounded fears, save MAOIs for a last resort; sometimes after ECT.
Most all medications can be dangerous if not used properly. A Google search of the words NSAIDS and Fatal comes up with 266,000 hits.I'm an analyzer and have been taking MAOIs for ten years; I'll pass on a few links.
Take care,
Jedihttp://www.dr-bob.org/babble/20060310/msgs/618676.html
http://www.dr-bob.org/babble/20060802/msgs/674323.html
http://www.dr-bob.org/babble/20050811/msgs/541577.html
http://www.dr-bob.org/babble/20060610/msgs/656744.html
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12950437&query_hl=6
Acta Psychiatr Scand Suppl. 2003;(417):65-71.
Pharmacotherapy of social phobia.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12607230&query_hl=11
World J Biol Psychiatry. 2000 Jan;1(1):27-33.
A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11801236&query_hl=11
Biol Psychiatry. 2002 Jan 1;51(1):109-20.
Pharmacotherapy of social anxiety disorder.http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1776507
Biochem Pharmacol. 2002 January 1; 63(1): 57–64.
Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular γ-aminobutyric acid levels in the striatumhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=1362653
J Psychiatry Neurosci. 1992 November; 17(5): 206–214.
Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.
poster:Jedi
thread:751719
URL: http://www.dr-bob.org/babble/20070419/msgs/752024.html